These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 15853618

  • 1. Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?
    Carro E, Torres-Aleman I.
    Expert Rev Neurother; 2004 Jan; 4(1):79-86. PubMed ID: 15853618
    [Abstract] [Full Text] [Related]

  • 2. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease.
    Carro E, Torres-Aleman I.
    Eur J Pharmacol; 2004 Apr 19; 490(1-3):127-33. PubMed ID: 15094079
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin and Alzheimer's disease: therapeutic prospects.
    Gard PR, Rusted JM.
    Expert Rev Neurother; 2004 Jan 19; 4(1):87-96. PubMed ID: 15853619
    [Abstract] [Full Text] [Related]

  • 4. Cystatin C: a potential target for Alzheimer's treatment.
    Levy E.
    Expert Rev Neurother; 2008 May 19; 8(5):687-9. PubMed ID: 18457524
    [No Abstract] [Full Text] [Related]

  • 5. [Therapy of Alzheimer disease].
    Kovács T.
    Neuropsychopharmacol Hung; 2009 Mar 19; 11(1):27-33. PubMed ID: 19731816
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.
    Sevigny JJ, Ryan JM, van Dyck CH, Peng Y, Lines CR, Nessly ML, MK-677 Protocol 30 Study Group.
    Neurology; 2008 Nov 18; 71(21):1702-8. PubMed ID: 19015485
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ, Barnham KJ, Bush AI, White AR.
    Drug News Perspect; 2006 Oct 18; 19(8):469-74. PubMed ID: 17160147
    [Abstract] [Full Text] [Related]

  • 8. Androgens and Alzheimer's disease.
    Drummond ES, Harvey AR, Martins RN.
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun 18; 16(3):254-9. PubMed ID: 19373081
    [Abstract] [Full Text] [Related]

  • 9. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease.
    Blain JF, Poirier J.
    Expert Rev Neurother; 2004 Sep 18; 4(5):823-9. PubMed ID: 15853509
    [Abstract] [Full Text] [Related]

  • 10. The immune system, amyloid-beta peptide, and Alzheimer's disease.
    Weksler ME, Gouras G, Relkin NR, Szabo P.
    Immunol Rev; 2005 Jun 18; 205():244-56. PubMed ID: 15882358
    [Abstract] [Full Text] [Related]

  • 11. Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?
    Carro E, Trejo JL, Spuch C, Bohl D, Heard JM, Torres-Aleman I.
    Neurobiol Aging; 2006 Nov 18; 27(11):1618-31. PubMed ID: 16274856
    [Abstract] [Full Text] [Related]

  • 12. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
    Crouch PJ, White AR, Bush AI.
    FEBS J; 2007 Aug 18; 274(15):3775-83. PubMed ID: 17617225
    [Abstract] [Full Text] [Related]

  • 13. Peripheral elevation of IGF-1 fails to alter Abeta clearance in multiple in vivo models.
    Lanz TA, Salatto CT, Semproni AR, Marconi M, Brown TM, Richter KE, Schmidt K, Nelson FR, Schachter JB.
    Biochem Pharmacol; 2008 Mar 01; 75(5):1093-103. PubMed ID: 18076866
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New roles for insulin-like hormones in neuronal signalling and protection: new hopes for novel treatments of Alzheimer's disease?
    Hölscher C, Li L.
    Neurobiol Aging; 2010 Sep 01; 31(9):1495-502. PubMed ID: 18930564
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V, Cribbs DH.
    Neurochem Int; 2006 Jul 01; 49(2):113-26. PubMed ID: 16765487
    [Abstract] [Full Text] [Related]

  • 19. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S, Rauk A.
    Med Hypotheses; 2005 Jul 01; 65(1):123-37. PubMed ID: 15893129
    [Abstract] [Full Text] [Related]

  • 20. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
    Montalto MC, Farrar G, Hehir CT.
    Ann N Y Acad Sci; 2007 Feb 01; 1097():239-58. PubMed ID: 17413026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.